Logo site
Activation navigation mobile
Menu
About us
Origin
Management Team
Scientific & Medical Advisors
Partners & Support
Science
Our scientific approach
Intellectual Property
Academic publications
Products
Our portfolio
GC01
Patients
Glioblastoma
Useful links
Media
Contact
Accueil
>
Media
>
Presse release
Presse release
Porsolt, GlioCure, and the University Hospital of Angers, will join forces in the “Glio Preclinical Solutions (GPS)”, collaborative project to develop new and innovative models for the evaluation of first- and best-in class innovative cancer therapies for
Publié le Thursday 23 June 2022
Angers and Le Genest-Saint-Isle, France – GlioCure, a biopharmaceutical company specializing in...
Learn more
Defymed and GlioCure initiate a collaboration in the field of solid tumors without therapeutic options
Publié le Wednesday 20 April 2022
Strasbourg and Angers - Defymed, a Strasbourg-based medical technology company,...
Learn more
GlioCure strengthens its management team with the recruitment of Dr. Sandrine Courtès as Director of Preclinical Development and Intellectual Property
Publié le Tuesday 22 June 2021
GlioCure SA, a biotechnology company specializing in neuro-oncology, announces the arrival of Dr....
Learn more
GlioCure expands its know-how and technological offer to nanovectors
Publié le Thursday 27 May 2021
Angers – GlioCure SA, a biotechnology company specializing in neuro-oncology,...
Learn more
GlioCure transforms into a Limited Liability Company and closes a new round of financing
Publié le Wednesday 21 April 2021
Angers, April 13th, 2021 – GlioCure, a preclinical-drug-development company...
Learn more
GlioCure finalises its seed capital with a financing from « French Tech Seed » and reports a second consecutive profitable year.
Publié le Tuesday 12 May 2020
Angers, May 12th, 2020 – GlioCure SAS, a biotech company specialised in neuro-oncology,...
Learn more
RELIEF, a strategic project for GlioCure, selected by EUREKA!
Publié le Tuesday 21 January 2020
Angers, France - GlioCure SAS, a biotechnology company specialized in neuro-oncology,...
Learn more
GlioCure receives the "Seal of Excellence" from the European Commission
Publié le Friday 21 June 2019
GlioCure was awarded the "Seal of Excellence" under the H2020 Instrument PME phase 1 scheme for...
Learn more
Merck Awards Grants to Biotechs Tackling Cancer and Cardiovascular Disease
Publié le Monday 4 February 2019
Three European companies to use Merck’s Advance Biotech Grant prizes to accelerate...
Learn more
An eminent oncologist joins the GlioCure Scientific and Medical Advisory Board
Publié le Thursday 6 July 2017
Dr. Jean-Pierre BIZZARI, world renowned expert in oncology, is joining GlioCure's Scientific and...
Learn more